Nombre del producto:2-(Difluoromethoxy)-7-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline

IUPAC Name:2-(difluoromethoxy)-7-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline

CAS:2073844-31-0
Fórmula molecular:C16H19BF2N2O3
Pureza:95%+
Número de catálogo:CM1050261
Peso molecular:336.15

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2073844-31-0
Fórmula molecular:C16H19BF2N2O3
Punto de fusión:-
Código de sonrisas:FC(F)OC1=NC2C(N=C1)=C(C=C(C)C=2)B3OC(C)(C)C(C)(C)O3
Densidad:
Número de catálogo:CM1050261
Peso molecular:336.15
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Related Products